Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.

被引：0
|
作者：
Herrmann, E.
Marschner, N.
Grimm, M.
Ohlmann, C. H.
Hutzschenreuther, U.
Overkamp, F.
Groschek, M.
Blumenstengel, K.
Steiner, T.
机构：
[1] Univ Munster, Dept Urol, D-48149 Munster, Germany
[2] Univ Dresden, Dept Urol, Dresden, Germany
[3] Univ Saarland, Homburg, Germany
[4] Helios Hosp, Dept Urol, Erfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15061
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
    Herrmann, E.
    Marschner, N.
    Grimm, M. O.
    Ohlmann, C. H.
    Hutzschenreuter, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Puehse, G.
    Steiner, T.
    [J]. WORLD JOURNAL OF UROLOGY, 2011, 29 (03) : 361 - 366
  • [2] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
    E. Herrmann
    N. Marschner
    M. O. Grimm
    C. H. Ohlmann
    U. Hutzschenreuter
    F. Overkamp
    M. Groschek
    K. Blumenstengel
    G. Pühse
    T. Steiner
    [J]. World Journal of Urology, 2011, 29 : 361 - 366
  • [3] A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
    Stenner, Frank
    Chastonay, Rahel
    Liewen, Heike
    Haile, Sarah R.
    Cathomas, Richard
    Rothermundt, Christian
    Siciliano, Raffaele D.
    Stoll, Susanna
    Knuth, Alexander
    Buchler, Tomas
    Porta, Camillo
    Renner, Christoph
    Samaras, Panagiotis
    [J]. ONCOLOGY, 2012, 82 (06) : 333 - 340
  • [4] Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
    Sablin, M. P.
    Negrier, S.
    Ravaud, A.
    Oudard, S.
    Balleyguier, C.
    Gautier, J.
    Celier, C.
    Medioni, J.
    Escudier, B.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (01): : 29 - 34
  • [5] predictive biomarkers for treatment selection of sorafenib or sunitinib in metastatic renal cell carcinoma.
    Naito, Sei
    Bilim, Vladimir
    Tsuchiya, Norihiko
    Tomita, Yoshihiko
    [J]. CANCER SCIENCE, 2021, 112 : 509 - 509
  • [6] Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
    Schlemmer, Marcus
    Spek, Annabel
    Rodler, Severin
    Schott, Melanie
    Casuscelli, Jozefina
    Staehler, Michael
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (03)
  • [7] Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
    Wen, Tingyu
    Xiao, Hai
    Luo, Chao
    Huang, Li
    Xiong, Meimei
    [J]. ONCOTARGET, 2017, 8 (12) : 20441 - 20451
  • [8] Re: Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02): : 824 - 825
  • [9] Sequential Therapy With Sorafenib and Sunitinib in Renal Cell Carcinoma
    Dudek, Arkadiusz Z.
    Zolnierek, Jakub
    Dham, Anu
    Lindgren, Bruce R.
    Szczylik, Cezary
    [J]. CANCER, 2009, 115 (01) : 61 - 67
  • [10] Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
    Dham, A.
    Dudek, A. Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345